Archive: Ross Marchand
Ross Marchand is a Catalyst Policy Fellow and the director of policy for the Taxpayers Protection Alliance. He focuses on a range of issues, ranging from health-care reform to internet regulation to Postal Service-related issues. Ross is an alumnus of the Mercatus Center MA Fellowship at George Mason University, where he received his MA in economics in 2016. He has interned for the Texas Public Policy Foundation and the American Legislative Exchange Council, analyzing and blogging on a variety of public policy issues.
A Tale of Two Drug Approvals
The FDA has a unique responsibility to approve game-changing medications in a timely manner.
Germany Shows Universal Healthcare Is No Panacea
The government mandates, standardizes, and subsidizes care, and yet, struggling citizens still get subpar care.
America Needs Doctors in the Digital Domain
Seeing the doctor could be a twenty-minute Skype session, instead of a day-long ordeal.
Study Committee Delivers on Bold New Healthcare Plan
A truly market-based healthcare system would deliver the goods, but only if Congress passes bold reforms.
There’s a Lack of Expertise on Capitol Hill. That’s Okay.
In-house expertise often stymies genuine intellectual debate by giving a single analysis an official stamp of approval.
Faux Globalism Benefits No One
Large reductions in pollution tend to happen as economic freedom increases and businesses invest in large-scale efficiency improvements.
FDA Must Allow, Not Thwart, Genetic Testing Revolution
Rather than restricting lifesaving innovations, the FDA should greenlight genetic testing and allow the market to develop.
We Already Have Government-Run Healthcare in US: Just Ask Native Americans
According to its patients, this much talked about “right” to healthcare amounts to very little in reality.
Lawmakers, Bureaucrats Need to End War on Video Games
Onerous government regulations of video games would raise prices on millions while harming mental health.
Why Cats Pay a Lower Price for CAT Scans
Increasing consumer exposure to prices and empowering them to pay medical expenses directly is key to keeping costs under control.
With the Right Reforms, Gene Therapy Can Cure Millions
Gene therapies carry tremendous potential, but this upside can only be realized via the comprehensive and coordinated reform of federal policies.